Skip to main content
Equibles

JUPITER ASSET MANAGEMENT LTD

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1215838 London, X0
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$11,599,189
+$667,459 QoQ
Shares Held
458,466
-6.6% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#49
of 354 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JUPITER ASSET MANAGEMENT LTD holds $354,007,590 across 28 Biotechnology names. ACAD ranks #9 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 126,099 $78,627,770
2 INCY
Incyte Corp
 511,050 $57,932,627
3 PTCT
Ptc Therapeutics, Inc.
 707,450 $57,706,695
4 NTLA
Intellia Therapeutics, Inc.
 1,849,507 $31,293,657
5 IOVA
Iovance Biotherapeutics, Inc.
 4,535,080 $18,865,932
6 AUPH
Aurinia Pharmaceuticals Inc.
 1,094,475 $18,573,240
7 BEAM
Beam Therapeutics Inc.
 445,718 $15,297,041
8 RLAY
Relay Therapeutics, Inc.
 719,576 $13,463,266

All Filings in ACAD

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,599,189 458,466
2026-03-31 $10,931,730 491,093
2025-12-31 $16,588,218 621,049
2025-09-30 $10,164,604 476,317
2025-06-30 $13,726,608 636,375
2025-03-31 $6,761,117 407,051
2024-09-30 $2,421,688 157,457
2024-06-30 $17,238,649 1,060,840
2024-03-31 $29,653,780 1,603,774
2023-12-31 $41,403,216 1,322,364
2023-09-30 $26,596,341 1,276,216
2023-06-30 $30,447,250 1,271,284
2023-03-31 $25,738,250 1,367,601
2022-12-31 $17,352,353 1,089,972
2022-09-30 $1,264,496 77,292
2022-06-30 $916,117 65,019
2020-09-30 $4,795,642 116,258